On balance, therefore, the current evidence indicates that Wnt signaling does not affect significantly the preference of β β-catenin for its binding partners. In any case, it would appear undesirable if, each time a cell is stimulated by Wnt, its adhesion to its neighbors were weakened due to a Wnt-induced diversion of β β-catenin from E-cadherin.
But the choice of β β-catenin between cell adhesion and Wnt signaling can evidently be affected by other signals. One of these is the phosphorylation of Y142 in β β-catenin imparted by the Met receptor tyrosine kinase [9] . As mentioned, this modification reduces β β-catenin's binding to α α-catenin, and favors its binding to BCL9-2. Indeed, overexpression of BCL9-2 in non-transformed epithelial cells causes β β-catenin to translocate into the nucleus and to stimulate TCF-mediated transcription.
In addition, the overexpressed BCL9-2 promotes migratory activity and scattering, so induces changes in epithelial cells that are akin to an epithelial-mesenchymal transition. These BCL9-2-induced changes are enhanced by subcritical stimulation of the Met receptor by hepatocyte growth factor. Therefore, the Y142 residue is a pivot under the control of extracellular growth factor signals, and can trigger an epithelial-mesenchymal transition by diverting β β-catenin from cell adhesion to Wnt signaling [9] .
It is conceivable that the β β-catenin binding protein APC may also have a role in the choice of β β-catenin between cell adhesion and Wnt signaling [16] . APC shuttles in and out of the nucleus, so encounters β β-catenin potentially in both subcellular compartments. 
